» Articles » PMID: 38165044

Immune Mechanisms of Granuloma Formation in Sarcoidosis and Tuberculosis

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2024 Jan 2
PMID 38165044
Authors
Affiliations
Soon will be listed here.
Abstract

Sarcoidosis is a complex immune-mediated disease characterized by clusters of immune cells called granulomas. Despite major steps in understanding the cause of this disease, many questions remain. In this Review, we perform a mechanistic interrogation of the immune activities that contribute to granuloma formation in sarcoidosis and compare these processes with its closest mimic, tuberculosis, highlighting shared and divergent immune activities. We examine how Mycobacterium tuberculosis is sensed by the immune system; how the granuloma is initiated, formed, and perpetuated in tuberculosis compared with sarcoidosis; and the role of major innate and adaptive immune cells in shaping these processes. Finally, we draw these findings together around several recent high-resolution studies of the granuloma in situ that utilized the latest advances in single-cell technology combined with spatial methods to analyze plausible disease mechanisms. We conclude with an overall view of granuloma formation in sarcoidosis.

Citing Articles

Alveolar macrophages from persons with HIV mount impaired TNF signaling networks to M. tuberculosis infection.

Kgoadi K, Bajpai P, Ibegbu C, Dkhar H, Enriquez A, Dawa S Nat Commun. 2025; 16(1):2397.

PMID: 40064940 PMC: 11894076. DOI: 10.1038/s41467-025-57668-y.


Gallbladder and liver miliary nodules: a surprising diagnosis of disseminated tuberculosis during emergency laparoscopic cholecystectomy.

Li T, Zhu L, Chen B, Wang M, Shi D, Lin C Int J Emerg Med. 2025; 18(1):44.

PMID: 40033227 PMC: 11877782. DOI: 10.1186/s12245-025-00855-x.


Cardiac Sarcoidosis: Clinical Insights, Diagnosis, and Management Strategies.

Farina N, Luca G, Peretto G, Bartoli A, Esposito A, Matucci-Cerinic M Rev Cardiovasc Med. 2025; 26(2):26605.

PMID: 40026523 PMC: 11868888. DOI: 10.31083/RCM26605.


Advances in Host-Pathogen Interactions in Tuberculosis: Emerging Strategies for Therapeutic Intervention.

Nasiri M, Venketaraman V Int J Mol Sci. 2025; 26(4).

PMID: 40004082 PMC: 11855387. DOI: 10.3390/ijms26041621.


Shaping Rare Granulomatous Diseases in the Lab: How New Models Are Changing the Game.

Ceccato J, Gualtiero G, Piazza M, Carraro S, Buso H, Felice C Cells. 2025; 14(4).

PMID: 39996765 PMC: 11853845. DOI: 10.3390/cells14040293.


References
1.
Tong X, Ma Y, Niu X, Yan Z, Liu S, Peng B . The BTNL2 G16071A gene polymorphism increases granulomatous disease susceptibility: A meta-analysis including FPRP test of 8710 participants. Medicine (Baltimore). 2016; 95(30):e4325. PMC: 5265849. DOI: 10.1097/MD.0000000000004325. View

2.
Chen E . Innate immunity in sarcoidosis pathobiology. Curr Opin Pulm Med. 2016; 22(5):469-75. DOI: 10.1097/MCP.0000000000000305. View

3.
Ginhoux F, Guilliams M . Tissue-Resident Macrophage Ontogeny and Homeostasis. Immunity. 2016; 44(3):439-449. DOI: 10.1016/j.immuni.2016.02.024. View

4.
Chen M, Divangahi M, Gan H, Shin D, Hong S, Lee D . Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. J Exp Med. 2008; 205(12):2791-801. PMC: 2585850. DOI: 10.1084/jem.20080767. View

5.
Pabst S, Franken T, Schonau J, Stier S, Nickenig G, Meyer R . Transforming growth factor-{beta} gene polymorphisms in different phenotypes of sarcoidosis. Eur Respir J. 2010; 38(1):169-75. DOI: 10.1183/09031936.00120410. View